Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations

[1]  Z. Bloomgarden.  Diabetes and branched‐chain amino acids: What is the link? , 2018, Journal of diabetes.

[2]  M. Ridderstråle,et al.  Amino Acid Signatures to Evaluate the Beneficial Effects of Weight Loss , 2017, International Journal of Endocrinology.

[3]  M. Adeva-Andany,et al.  Enzymes involved in branched-chain amino acid metabolism in humans , 2017, Amino Acids.

[4]  E. Fukusaki,et al.  Increased Dynamics of Tricarboxylic Acid Cycle and Glutamate Synthesis in Obese Adipose Tissue , 2017, The Journal of Biological Chemistry.

[5]  M. Nishimura,et al.  Associations among the plasma amino acid profile, obesity, and glucose metabolism in Japanese adults with normal glucose tolerance , 2016, Nutrition & Metabolism.

[6]  A. Marette,et al.  Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. , 2015, American journal of physiology. Endocrinology and metabolism.

[7]  Nicholette D. Palmer,et al.  Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. , 2015, The Journal of clinical endocrinology and metabolism.

[8]  R. Sinha,et al.  Human metabolic correlates of body mass index , 2014, Metabolomics.

[9]  F. Haj,et al.  Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. , 2013, American journal of physiology. Endocrinology and metabolism.

[10]  E. Gibney,et al.  The relationship between BMI and metabolomic profiles: a focus on amino acids , 2012, Proceedings of the Nutrition Society.

[11]  Y. Ishizaka,et al.  Plasma amino acid profile is associated with visceral fat accumulation in obese Japanese subjects , 2012, Clinical obesity.

[12]  B. Kahn,et al.  Adipose Tissue Branched Chain Amino Acid (BCAA) Metabolism Modulates Circulating BCAA Levels* , 2010, The Journal of Biological Chemistry.

[13]  Wei Jia,et al.  Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. , 2009, Journal of proteome research.

[14]  Marcus D. Ruopp,et al.  Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of Detection , 2008, Biometrical journal. Biometrische Zeitschrift.

[15]  Leena Peltonen,et al.  Global Transcript Profiles of Fat in Monozygotic Twins Discordant for BMI: Pathways behind Acquired Obesity , 2008, PLoS medicine.

[16]  Pengxiang She,et al.  Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. , 2007, American journal of physiology. Endocrinology and metabolism.

[17]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[18]  J. Després,et al.  Effects of Diet and Physical Activity on Adiposity and Body Fat Distribution: Implications for the Prevention of Cardiovascular Disease , 1993, Nutrition Research Reviews.

[19]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[20]  André Tchernof,et al.  Pathophysiology of human visceral obesity: an update. , 2013, Physiological reviews.

[21]  M. Patlas,et al.  The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. , 2012, The British journal of radiology.

[22]  R. Vasan,et al.  Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans , 2012 .

[23]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.